What is AML and why does it need funding?
- Pediatric cancer as a whole only receives 4% of the national funding for cancer research.
- AML also receives very little funding compared to other pediatric cancers, as it is not seen as a pediatric cancer. However, more than 600 children a year are diagnosed with AML.
- AML also currently has very few clinical trials to improve the types of medication that are used.
- AML’s treatment is brutal. It has a high mortality rate due to organ failure and sepsis. In addition, the treatment increases children’s risks of secondary cancers.
- Currently the chemotherapy to treat AML has not changed much in the last 20 years.
Lolo’s Angels intends to change this by developing awareness campaigns and raising money for pediatric AML research.
PLEASE JOIN IN OUR FIGHT AGAINST PEDIATRIC AML.
Copyright © 2017 Lolo's Angels, Inc.
Lolo's Angels, Inc. is a 501c3 non-profit. Donations are tax-deductible.